List of Tables
Table 1. Drugs for Anti-Infective Market Trends
Table 2. Drugs for Anti-Infective Market Drivers & Opportunity
Table 3. Drugs for Anti-Infective Market Challenges
Table 4. Drugs for Anti-Infective Market Restraints
Table 5. Global Drugs for Anti-Infective Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Drugs for Anti-Infective Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Drugs for Anti-Infective Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Drugs for Anti-Infective Product Type
Table 9. Key Companies Time to Begin Mass Production of Drugs for Anti-Infective
Table 10. Global Drugs for Anti-Infective Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Anti-Infective as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Drugs for Anti-Infective Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Drugs for Anti-Infective Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Drugs for Anti-Infective Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Drugs for Anti-Infective Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Drugs for Anti-Infective Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Drugs for Anti-Infective Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Drugs for Anti-Infective Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Drugs for Anti-Infective Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Drugs for Anti-Infective Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Drugs for Anti-Infective Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Drugs for Anti-Infective Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Drugs for Anti-Infective Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Drugs for Anti-Infective Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Drugs for Anti-Infective Sales Value by Region (2019-2024) & (%)
Table 27. Global Drugs for Anti-Infective Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Drugs for Anti-Infective Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Drugs for Anti-Infective Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Drugs for Anti-Infective Sales Value, (2025-2030) & (US$ Million)
Table 31. GlaxoSmithKline Basic Information List
Table 32. GlaxoSmithKline Description and Business Overview
Table 33. GlaxoSmithKline Drugs for Anti-Infective Products, Services and Solutions
Table 34. Revenue (US$ Million) in Drugs for Anti-Infective Business of GlaxoSmithKline (2019-2024)
Table 35. GlaxoSmithKline Recent Developments
Table 36. Merck Basic Information List
Table 37. Merck Description and Business Overview
Table 38. Merck Drugs for Anti-Infective Products, Services and Solutions
Table 39. Revenue (US$ Million) in Drugs for Anti-Infective Business of Merck (2019-2024)
Table 40. Merck Recent Developments
Table 41. Pfizer Basic Information List
Table 42. Pfizer Description and Business Overview
Table 43. Pfizer Drugs for Anti-Infective Products, Services and Solutions
Table 44. Revenue (US$ Million) in Drugs for Anti-Infective Business of Pfizer (2019-2024)
Table 45. Pfizer Recent Developments
Table 46. Novartis AG Basic Information List
Table 47. Novartis AG Description and Business Overview
Table 48. Novartis AG Drugs for Anti-Infective Products, Services and Solutions
Table 49. Revenue (US$ Million) in Drugs for Anti-Infective Business of Novartis AG (2019-2024)
Table 50. Novartis AG Recent Developments
Table 51. Gilead Sciences Basic Information List
Table 52. Gilead Sciences Description and Business Overview
Table 53. Gilead Sciences Drugs for Anti-Infective Products, Services and Solutions
Table 54. Revenue (US$ Million) in Drugs for Anti-Infective Business of Gilead Sciences (2019-2024)
Table 55. Gilead Sciences Recent Developments
Table 56. Abbott Basic Information List
Table 57. Abbott Description and Business Overview
Table 58. Abbott Drugs for Anti-Infective Products, Services and Solutions
Table 59. Revenue (US$ Million) in Drugs for Anti-Infective Business of Abbott (2019-2024)
Table 60. Abbott Recent Developments
Table 61. Sanofi-Aventis Basic Information List
Table 62. Sanofi-Aventis Description and Business Overview
Table 63. Sanofi-Aventis Drugs for Anti-Infective Products, Services and Solutions
Table 64. Revenue (US$ Million) in Drugs for Anti-Infective Business of Sanofi-Aventis (2019-2024)
Table 65. Sanofi-Aventis Recent Developments
Table 66. Bristol-Myers Squibb Basic Information List
Table 67. Bristol-Myers Squibb Description and Business Overview
Table 68. Bristol-Myers Squibb Drugs for Anti-Infective Products, Services and Solutions
Table 69. Revenue (US$ Million) in Drugs for Anti-Infective Business of Bristol-Myers Squibb (2019-2024)
Table 70. Bristol-Myers Squibb Recent Developments
Table 71. Johnson Basic Information List
Table 72. Johnson Description and Business Overview
Table 73. Johnson Drugs for Anti-Infective Products, Services and Solutions
Table 74. Revenue (US$ Million) in Drugs for Anti-Infective Business of Johnson (2019-2024)
Table 75. Johnson Recent Developments
Table 76. Roche Pharma AG Basic Information List
Table 77. Roche Pharma AG Description and Business Overview
Table 78. Roche Pharma AG Drugs for Anti-Infective Products, Services and Solutions
Table 79. Revenue (US$ Million) in Drugs for Anti-Infective Business of Roche Pharma AG (2019-2024)
Table 80. Roche Pharma AG Recent Developments
Table 81. Nanosphere Basic Information List
Table 82. Nanosphere Description and Business Overview
Table 83. Nanosphere Drugs for Anti-Infective Products, Services and Solutions
Table 84. Revenue (US$ Million) in Drugs for Anti-Infective Business of Nanosphere (2019-2024)
Table 85. Nanosphere Recent Developments
Table 86. NanoViricides Basic Information List
Table 87. NanoViricides Description and Business Overview
Table 88. NanoViricides Drugs for Anti-Infective Products, Services and Solutions
Table 89. Revenue (US$ Million) in Drugs for Anti-Infective Business of NanoViricides (2019-2024)
Table 90. NanoViricides Recent Developments
Table 91. Novabay Pharmaceuticals Basic Information List
Table 92. Novabay Pharmaceuticals Description and Business Overview
Table 93. Novabay Pharmaceuticals Drugs for Anti-Infective Products, Services and Solutions
Table 94. Revenue (US$ Million) in Drugs for Anti-Infective Business of Novabay Pharmaceuticals (2019-2024)
Table 95. Novabay Pharmaceuticals Recent Developments
Table 96. Obetech Basic Information List
Table 97. Obetech Description and Business Overview
Table 98. Obetech Drugs for Anti-Infective Products, Services and Solutions
Table 99. Revenue (US$ Million) in Drugs for Anti-Infective Business of Obetech (2019-2024)
Table 100. Obetech Recent Developments
Table 101. Optimer Pharmaceuticals Basic Information List
Table 102. Optimer Pharmaceuticals Description and Business Overview
Table 103. Optimer Pharmaceuticals Drugs for Anti-Infective Products, Services and Solutions
Table 104. Revenue (US$ Million) in Drugs for Anti-Infective Business of Optimer Pharmaceuticals (2019-2024)
Table 105. Optimer Pharmaceuticals Recent Developments
Table 106. Basilea Pharmaceutica AG Basic Information List
Table 107. Basilea Pharmaceutica AG Description and Business Overview
Table 108. Basilea Pharmaceutica AG Drugs for Anti-Infective Products, Services and Solutions
Table 109. Revenue (US$ Million) in Drugs for Anti-Infective Business of Basilea Pharmaceutica AG (2019-2024)
Table 110. Basilea Pharmaceutica AG Recent Developments
Table 111. Daiichi Sankyo Basic Information List
Table 112. Daiichi Sankyo Description and Business Overview
Table 113. Daiichi Sankyo Drugs for Anti-Infective Products, Services and Solutions
Table 114. Revenue (US$ Million) in Drugs for Anti-Infective Business of Daiichi Sankyo (2019-2024)
Table 115. Daiichi Sankyo Recent Developments
Table 116. Key Raw Materials Lists
Table 117. Raw Materials Key Suppliers Lists
Table 118. Drugs for Anti-Infective Downstream Customers
Table 119. Drugs for Anti-Infective Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
Table 123. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Drugs for Anti-Infective Product Picture
Figure 2. Global Drugs for Anti-Infective Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Drugs for Anti-Infective Sales Value (2019-2030) & (US$ Million)
Figure 4. Drugs for Anti-Infective Report Years Considered
Figure 5. Global Drugs for Anti-Infective Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Drugs for Anti-Infective Revenue in 2023
Figure 7. Drugs for Anti-Infective Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. OTC Picture
Figure 9. Rx Drugs Picture
Figure 10. Global Drugs for Anti-Infective Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Drugs for Anti-Infective Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Hospital
Figure 13. Product Picture of Drugs Store
Figure 14. Product Picture of Other
Figure 15. Global Drugs for Anti-Infective Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Drugs for Anti-Infective Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Drugs for Anti-Infective Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Drugs for Anti-Infective Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Drugs for Anti-Infective Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Drugs for Anti-Infective Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Drugs for Anti-Infective Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Drugs for Anti-Infective Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Drugs for Anti-Infective Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Drugs for Anti-Infective Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Drugs for Anti-Infective Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Drugs for Anti-Infective Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Drugs for Anti-Infective Sales Value (%), (2019-2030)
Figure 28. United States Drugs for Anti-Infective Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Drugs for Anti-Infective Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Drugs for Anti-Infective Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Drugs for Anti-Infective Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Drugs for Anti-Infective Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Drugs for Anti-Infective Sales Value by Application (%), 2023 VS 2030
Figure 34. China Drugs for Anti-Infective Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Drugs for Anti-Infective Sales Value by Type (%), 2023 VS 2030
Figure 36. China Drugs for Anti-Infective Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Drugs for Anti-Infective Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Drugs for Anti-Infective Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Drugs for Anti-Infective Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Drugs for Anti-Infective Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Drugs for Anti-Infective Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Drugs for Anti-Infective Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Drugs for Anti-Infective Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Drugs for Anti-Infective Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Drugs for Anti-Infective Sales Value by Application (%), 2023 VS 2030
Figure 46. India Drugs for Anti-Infective Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Drugs for Anti-Infective Sales Value by Type (%), 2023 VS 2030
Figure 48. India Drugs for Anti-Infective Sales Value by Application (%), 2023 VS 2030
Figure 49. Drugs for Anti-Infective Industrial Chain
Figure 50. Drugs for Anti-Infective Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
